Heart failure & cardiomyopathiesResearch article
Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic Cardiomyopathy
- Narrative review
Study context
- Population
- Nonobstructive hypertrophic cardiomyopathy (HCM)
Main finding
As reported in the abstract
Prevalence and morbidity of nonobstructive HCM
Estimated prevalence of HCM
over 1 in 500 individuals
Share of HCM cases that are nonobstructive
approximately 30% to 70%
Original publication
Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic Cardiomyopathy. JACC Heart Fail. Published 24 September 2025. doi:10.1016/j.jchf.2025.102658
Summarised from the published abstract; every number is checked against it